ZilentixAltona into the tecHHub Hamburg in Innovationspark Altona Innovationspark Glioblastoma is the most common malignant form of brain tumor, and a definitive cure is not yet possible. The start-up company Zilentix has now developed a treatment method that promises a decisive breakthrough. This method uses transformed viruses as helpers. The deadly characteristics of glioblastoma Simply put...
Zilentix develops groundbreaking therapy for brain tumors